NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin
暂无分享,去创建一个
[1] C. Chougnet,et al. The aged nonhematopoietic environment impairs natural killer cell maturation and function , 2015, Aging cell.
[2] Nicolás I Torres,et al. IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness , 2015, European journal of immunology.
[3] O. Mandelboim,et al. NK cell development in bone marrow and liver: site matters , 2014, Genes and Immunity.
[4] O. Lambotte,et al. High Eomesodermin Expression among CD57+ CD8+ T Cells Identifies a CD8+ T Cell Subset Associated with Viral Control during Chronic Human Immunodeficiency Virus Infection , 2014, Journal of Virology.
[5] Hyun-Dong Chang,et al. NK cells gain higher IFN‐γ competence during terminal differentiation , 2014, European journal of immunology.
[6] O. Mandelboim,et al. NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease , 2014, Cell reports.
[7] M. Betts,et al. Characterization of T-Bet and Eomes in Peripheral Human Immune Cells , 2014, Front. Immunol..
[8] Satoru Takahashi,et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow , 2014, The Journal of experimental medicine.
[9] A. Agha,et al. KLRG1+ NK Cells Protect T-bet–Deficient Mice from Pulmonary Metastatic Colorectal Carcinoma , 2014, The Journal of Immunology.
[10] E. Riley,et al. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..
[11] H. Kohrt,et al. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. , 2012, Blood.
[12] T. Niki,et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. , 2012, Blood.
[13] Sharline Madera,et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. , 2012, Immunity.
[14] Jeffrey S. Miller,et al. NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions. , 2011, Blood.
[15] P. J. Norris,et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.
[16] P. Debré,et al. CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation , 2011, The Journal of Immunology.
[17] H. Pircher,et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.
[18] J. Passweg,et al. CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells , 2010, European journal of immunology.
[19] R. Negrin,et al. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. , 2010, Blood.
[20] M. Bevan,et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. , 2010, Immunity.
[21] A. Rao,et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs , 2009, The Journal of experimental medicine.
[22] J. Passweg,et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans , 2008, Seminars in Immunopathology.
[23] M. Robin,et al. An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation1 , 2008, The Journal of Immunology.
[24] M. Robin,et al. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. , 2008, Journal of immunology.
[25] M. Caligiuri,et al. Transcriptional control of human T‐BET expression: The role of Sp1 , 2007, European journal of immunology.
[26] B. Chapuis,et al. Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[27] E. Wherry,et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin , 2005, Nature Immunology.
[28] P. Farnham,et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. , 2004, Immunity.
[29] Hao Shen,et al. Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin , 2003, Science.
[30] D. Foster,et al. IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells1 , 2003, The Journal of Immunology.
[31] D. Foster,et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. , 2003, Journal of immunology.